Werner Lutz focuses on Carcinogen, Genotoxicity, Molecular biology, Biochemistry and DNA. His Carcinogen study integrates concerns from other disciplines, such as Carcinogenesis, Toxicology, Endogeny, Stimulation and Toxicity. His research integrates issues of Emodin, DNA damage, Mutagen, Micronucleus test and Topoisomerase-II Inhibitor in his study of Genotoxicity.
His Molecular biology study combines topics in areas such as DNA fragmentation and Programmed cell death. His Rat liver and Toxicokinetics study in the realm of Biochemistry connects with subjects such as Action and Ethyl carbamate. The various areas that he examines in his DNA study include Irreversible binding, Gene, In vivo and Saccharin.
The scientist’s investigation covers issues in Carcinogen, DNA, Biochemistry, Genotoxicity and Molecular biology. His Carcinogen research incorporates elements of Carcinogenesis, Internal medicine, Toxicity and Toxicology. Werner Lutz has researched DNA in several fields, including Adduct, Nucleotide, In vivo and Aflatoxin.
His Biochemistry research focuses on Chromatography and how it relates to Urine. His Genotoxicity research integrates issues from Emodin, Pharmacology, Comet assay and Micronucleus test. Werner Lutz combines subjects such as Mutant, Viability assay and DNA fragmentation, Programmed cell death with his study of Molecular biology.
His primary scientific interests are in Pharmacology, Biochemistry, Metabolite, Genotoxicity and Toxicity. The study incorporates disciplines such as Adduct and Organic chemistry in addition to Biochemistry. His biological study spans a wide range of topics, including Chemical carcinogens, Micronucleus test and Comet assay.
His Toxicity research incorporates themes from Toxicology, Log-normal distribution, Distribution, In vivo and Metabolism. His Internal medicine research includes elements of Diabetes mellitus, Cell growth and Carcinogen. His DNA damage study deals with the bigger picture of DNA.
Werner Lutz spends much of his time researching Miconazole, Steroid biosynthesis, Chromatography, Pharmacology and Biochemistry. His work deals with themes such as Metabolite and Steroid, which intersect with Chromatography. His Metabolite study incorporates themes from Calibration curve, Selected reaction monitoring, Triple quadrupole mass spectrometer, Principal component analysis and Lc ms ms.
Werner Lutz has included themes like CYP3A4 and Sunitinib in his Pharmacology study. His Biochemistry study focuses on Oxidative stress in particular. His work carried out in the field of High-performance liquid chromatography brings together such families of science as Column chromatography, Deoxyguanosine, DNA, DNA repair and Liquid chromatography–mass spectrometry.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
In vivo covalent binding of organic chemicals to DNA as a quantitative indicator in the process of chemical carcinogenesis.
Werner K. Lutz.
Mutation Research/reviews in Genetic Toxicology (1979)
Essential function of p300 acetyltransferase activity in heart, lung and small intestine formation.
Noriko Shikama;Werner Lutz;Ralph Kretzschmar;Nadine Sauter.
The EMBO Journal (2003)
Endogenous genotoxic agents and processes as a basis of spontaneous carcinogenesis.
Werner K. Lutz.
Mutation Research (1990)
Differential role of p300 and CBP acetyltransferase during myogenesis: p300 acts upstream of MyoD and Myf5.
Jeanne-Françoise Roth;Noriko Shikama;Clea Henzen;Isabelle Desbaillets.
The EMBO Journal (2003)
Genotoxicity of the laxative drug components emodin, aloe-emodin and danthron in mammalian cells: Topoisomerase II mediated?
Stefan O. Müller;Inge Eckert;Werner K. Lutz;Helga Stopper.
Mutation Research/genetic Toxicology (1996)
Correlation of DNA adduct levels with tumor incidence: carcinogenic potency of DNA adducts.
Michael Otteneder;Werner K. Lutz.
Mutation Research (1999)
Metabolic profiling of glucuronides in human urine by LC-MS/MS and partial least-squares discriminant analysis for classification and prediction of gender.
Ursula Lutz;Roman W. Lutz;Werner K. Lutz.
Analytical Chemistry (2006)
Quantitative evaluation of DNA binding data for risk estimation and for classification of direct and indirect carcinogens.
Werner K. Lutz.
Journal of Cancer Research and Clinical Oncology (1986)
MycN and IFNγ cooperate in apoptosis of human neuroblastoma cells
Werner Lutz;Simone Fulda;Irmela Jeremias;Klaus Michael Debatin.
Oncogene (1998)
On the Role of DNA Double-Strand Breaks in Toxicity and Carcinogenesis
Spiros Vamvakas;Esther H. Vock;Werner K. Lutz.
Critical Reviews in Toxicology (1997)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Würzburg
German Cancer Research Center
University of Lausanne
Ruhr University Bochum
Research Triangle Park Foundation
University of Würzburg
University of Ottawa
University of Duisburg-Essen
Queen Mary University of London
University Hospital Bonn
Georgia Institute of Technology
Case Western Reserve University
University of California, Berkeley
University of Wisconsin–Madison
University of Wisconsin–Madison
University of Oxford
Massey University
Florida State University
University at Albany, State University of New York
University of Maryland, College Park
Baylor College of Medicine
University of Hong Kong
University of Exeter
Duke University
Durham University
Max Planck Society